These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


179 related items for PubMed ID: 9018113

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Radiation-induced G1 arrest is not defective in fibroblasts from Li-Fraumeni families without TP53 mutations.
    Boyle JM, Greaves MJ, Camplejohn RS, Birch JM, Roberts SA, Varley JM.
    Br J Cancer; 1999 Apr; 79(11-12):1657-64. PubMed ID: 10206274
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Aberrant p21WAF1-dependent growth arrest as the possible mechanism of abnormal resistance to ultraviolet light cytotoxicity in Li-Fraumeni syndrome fibroblast strains heterozygous for TP53 mutations.
    Barley RD, Enns L, Paterson MC, Mirzayans R.
    Oncogene; 1998 Aug 06; 17(5):533-43. PubMed ID: 9704919
    [Abstract] [Full Text] [Related]

  • 6. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype.
    Olivier M, Goldgar DE, Sodha N, Ohgaki H, Kleihues P, Hainaut P, Eeles RA.
    Cancer Res; 2003 Oct 15; 63(20):6643-50. PubMed ID: 14583457
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 mutation.
    Capponcelli S, Pedrini E, Cerone MA, Corti V, Fontanesi S, Alessio M, Bachi A, Soddu S, Ribatti D, Picci P, Helman LJ, Cantelli-Forti G, Sangiorgi L.
    Hum Mutat; 2005 Aug 15; 26(2):94-103. PubMed ID: 15977174
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Detection of both mutant and wild-type p53 protein in normal skin fibroblasts and demonstration of a shared 'second hit' on p53 in diverse tumors from a cancer-prone family with Li-Fraumeni syndrome.
    Srivastava S, Tong YA, Devadas K, Zou ZQ, Sykes VW, Chen Y, Blattner WA, Pirollo K, Chang EH.
    Oncogene; 1992 May 15; 7(5):987-91. PubMed ID: 1373881
    [Abstract] [Full Text] [Related]

  • 12. Tissue-specific expression of SV40 in tumors associated with the Li-Fraumeni syndrome.
    Malkin D, Chilton-MacNeill S, Meister LA, Sexsmith E, Diller L, Garcea RL.
    Oncogene; 2001 Jul 27; 20(33):4441-9. PubMed ID: 11494139
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The TP53 gene promoter is not methylated in families suggestive of Li-Fraumeni syndrome with no germline TP53 mutations.
    Finkova A, Vazna A, Hrachovina O, Bendova S, Prochazkova K, Sedlacek Z.
    Cancer Genet Cytogenet; 2009 Aug 27; 193(1):63-6. PubMed ID: 19602465
    [Abstract] [Full Text] [Related]

  • 15. No defect in G1/S cell cycle arrest in irradiated Li-Fraumeni lymphoblastoid cell lines.
    Williams KJ, Heighway J, Birch JM, Norton JD, Scott D.
    Br J Cancer; 1996 Sep 27; 74(5):698-703. PubMed ID: 8795570
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. In vitro transformation of Li-Fraumeni syndrome fibroblasts by SV40 large T antigen mutants.
    Maclean K, Rogan EM, Whitaker NJ, Chang AC, Rowe PB, Dalla-Pozza L, Symonds G, Reddel RR.
    Oncogene; 1994 Mar 27; 9(3):719-25. PubMed ID: 8108114
    [Abstract] [Full Text] [Related]

  • 19. [Li-Fraumeni syndrome: update, new data and guidelines for clinical management].
    Frebourg T, Abel A, Bonaiti-Pellie C, Brugières L, Berthet P, Bressac-de Paillerets B, Chevrier A, Chompret A, Cohen-Haguenauer O, Delattre O, Feingold J, Feunteun J, Frappaz D, Fricker JP, Gesta P, Jonveaux P, Kalifa C, Lasset C, Leheup B, Limacher JM, Longy M, Nogues C, Oppenheim D, Sommelet D, Soubrier F, Stoll C, Stoppa-Lyonnet D, Tristant H.
    Bull Cancer; 2001 Jun 27; 88(6):581-7. PubMed ID: 11459705
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.